DK1155014T3 - Hidtil ukendte benzimidazolforbindelser til anvendelse som aktive, terapeutiske stoffer, fremgangsmåde til fremstilling af disse forbindelser og farmaceutiske sammensætninger omfattende dem - Google Patents

Hidtil ukendte benzimidazolforbindelser til anvendelse som aktive, terapeutiske stoffer, fremgangsmåde til fremstilling af disse forbindelser og farmaceutiske sammensætninger omfattende dem

Info

Publication number
DK1155014T3
DK1155014T3 DK00902282T DK00902282T DK1155014T3 DK 1155014 T3 DK1155014 T3 DK 1155014T3 DK 00902282 T DK00902282 T DK 00902282T DK 00902282 T DK00902282 T DK 00902282T DK 1155014 T3 DK1155014 T3 DK 1155014T3
Authority
DK
Denmark
Prior art keywords
alkyl
compounds
substituted
aryl
processes
Prior art date
Application number
DK00902282T
Other languages
English (en)
Inventor
Charles Hedgecock
Eric Desarbre
Guido Kurz
Martin Norin
Marguerite Luthman
Hl Cathrin Widerst
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Application granted granted Critical
Publication of DK1155014T3 publication Critical patent/DK1155014T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK00902282T 1999-01-25 2000-01-24 Hidtil ukendte benzimidazolforbindelser til anvendelse som aktive, terapeutiske stoffer, fremgangsmåde til fremstilling af disse forbindelser og farmaceutiske sammensætninger omfattende dem DK1155014T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9900211A SE9900211D0 (sv) 1999-01-25 1999-01-25 New compounds
PCT/SE2000/000144 WO2000043387A1 (en) 1999-01-25 2000-01-24 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
DK1155014T3 true DK1155014T3 (da) 2003-09-29

Family

ID=20414207

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00902282T DK1155014T3 (da) 1999-01-25 2000-01-24 Hidtil ukendte benzimidazolforbindelser til anvendelse som aktive, terapeutiske stoffer, fremgangsmåde til fremstilling af disse forbindelser og farmaceutiske sammensætninger omfattende dem

Country Status (12)

Country Link
EP (1) EP1155014B1 (da)
JP (1) JP2002535325A (da)
AT (1) ATE242237T1 (da)
AU (1) AU760346B2 (da)
CA (1) CA2359107A1 (da)
DE (1) DE60003158T2 (da)
DK (1) DK1155014T3 (da)
ES (1) ES2202045T3 (da)
NZ (1) NZ512597A (da)
PT (1) PT1155014E (da)
SE (1) SE9900211D0 (da)
WO (1) WO2000043387A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010036613A1 (en) * 2008-09-26 2010-04-01 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) * 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
EP2640705A2 (en) 2010-11-15 2013-09-25 Katholieke Universiteit Leuven Novel antiviral compounds

Also Published As

Publication number Publication date
DE60003158D1 (de) 2003-07-10
AU760346B2 (en) 2003-05-15
JP2002535325A (ja) 2002-10-22
ATE242237T1 (de) 2003-06-15
SE9900211D0 (sv) 1999-01-25
EP1155014A1 (en) 2001-11-21
DE60003158T2 (de) 2003-12-04
NZ512597A (en) 2003-12-19
WO2000043387A1 (en) 2000-07-27
ES2202045T3 (es) 2004-04-01
AU2340600A (en) 2000-08-07
EP1155014B1 (en) 2003-06-04
CA2359107A1 (en) 2000-07-27
PT1155014E (pt) 2003-10-31

Similar Documents

Publication Publication Date Title
ATE327977T1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
TR200201874T2 (tr) Proteaz inhibitörleri olarak yeni bileşikler ve bileşimler.
AR027548A1 (es) Derivados de amino pirazol utiles para el tratamiento de la obesidad y otros desordenes
DK1487829T3 (da) Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte
PL372319A1 (en) Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
ECSP055671A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesteresa
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
EA200500405A1 (ru) Твёрдые фармацевтические лекарственные формы, включающие телмисартан
ATE302775T1 (de) Carbolinderivate
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
ATE346067T1 (de) Carbolinderivate
BR0207872A (pt) Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração
AR054508A1 (es) Compuesto de bencilpiperazina, su uso para preparar un medicamento, procedimientos para la preparacion de dicho compuesto y de compuestos intermediarios, dichos compuestos intermediarios, composicion farmaceutica que lo comprende y procedimiento para prepararla
ATE300543T1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
ATE302203T1 (de) Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen
AR039190A1 (es) Derivados de benzofurano, composicion farmaceutica y medicamento que comprende el compuesto
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
DK1189900T3 (da) Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler
AR038332A1 (es) Compuestos que son metabolitos del acido (3-{[(4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi) acetico, composiciones farmaceuticas que los contienen, y procedimiento de determinacion
AR038143A1 (es) Agonistas del receptor 2 del factor liberador de la corticotropina
SE0301699D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
NO20014855D0 (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
DK1155014T3 (da) Hidtil ukendte benzimidazolforbindelser til anvendelse som aktive, terapeutiske stoffer, fremgangsmåde til fremstilling af disse forbindelser og farmaceutiske sammensætninger omfattende dem